Experimental design and desirability function approach for development of novel anticancer nanocarrier delivery systems

Pharmazie

Volumn 66, Issue 1, 2011, Pages 31-36

  Rafati, Hasan ^a   Mirzajani, F ^a  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

NANOCARRIER; NANOPARTICLE; TAMOXIFEN CITRATE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; DRUG CARRIER; EXCIPIENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYVINYL ALCOHOL; TAMOXIFEN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; ENCAPSULATION; EXPERIMENTAL STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ALGORITHM; DRUG FORMULATION; STATISTICAL MODEL;

ALGORITHMS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; EXCIPIENTS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MODELS, STATISTICAL; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYVINYL ALCOHOL; TAMOXIFEN;

EID: 79953310175     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0221     Document Type: Article

References (29)

1. Astier A, Doat B, Ferrer MJ, Benoit G, Fleury J, Rolland A, Leverge R (1988) Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells. Cancer Res 48: 1835-1841.
2. Bempong DK (2005) (DMPS05) Monograph development-pulmonary and steroids. US Pharmacopoeia 27: 2779.
3. Berzas JJ, Rodriguez J, Contento AM, Cabello MP (2003) Determination of drugs used in advanced breast cancer by capillary gas chromatography of pharmaceutical formulation. J Sep Sci 26: 908-914. (Pubitemid 36934549)
4. Bourguignon B, Massart DL (1991) Simultaneous optimization of several chromatographic performance goals using Derringer's desirability function. J Chromatogr A 586: 11-20.
5. Brannon-Peppas L (1995) Recent advances in the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int J Pharm 116: 1-9.
6. Corrada Y, Arias D, Rodríguez R, Spaini E, Fava F, Gobello C (2004) Effect of tamoxifen citrate on reproductive parameters of male dogs. Theriogenology 61: 1327-1341. (Pubitemid 38300345)
7. Couvreur P, Tulkens P, Roland M, Trouet A, Speiser P (1977) Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett 84: 323-326. (Pubitemid 8246984)
8. Curtis RE, Boice J, JD Jr, Shriner DA, Hankey BF, Fraumeni JF Jr. (1996) Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst. 88: 832-834. (Pubitemid 26187392)
9. Dai J, Nagai T, Wang X, Zhang T, Meng M, Zhang Q (2004) pH-Sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm 280: 229-240. (Pubitemid 38950919)
10. Duan Y, Xu S, ang Q, Liu J, Zhang Z (2006) Optimization of preparation of DHAQ-loaded PEG-PLGA-PEG nanoparticles using central composite design. J Mater Sci Mater Med 17: 559-563.
11. Esmaeili F, Atyabi F, Dinarvand R (2008) Preparation and characterization of estradiol-loaded PLGA nanoparticles using homogenization-solvent diffusion method. Daru 16: 196-202.
12. Freitas JRA (2005) What is nanomedicine? Nanomedicine 1: 2-9.
13. Garnett MC (2001) Targeted drug conjugates: principles and progress. Adv Drug Deliv Rev 53: 171-216.
14. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS (1999) PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 57: 171-85. (Pubitemid 29062869)
15. Hans L, Lowman AM (2002) Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 6: 319-27.
16. Jimidar M, Bourguignon B, Massart DL (1996) Application of Derringer's desirability function for the selection of optimum separation conditions in capillary zone electrophoresis. J Chromatogr A 740: 109-117. (Pubitemid 26295379)
17. Kumar CSSR (2006) Biological and Pharmaceutical Nanoparticles. Weinheim, Wiley-VCH Verlag GmbH.
18. Lee ES, Shin HJ, Na K, Bae YH (2003) Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release 90: 363-374. (Pubitemid 36859967)
19. Mirzajani F, Rafati H, Atyabi F (2010) Fabrication of biodegradable poly (d,l-lactide-co-glycolide) nanoparticles containing tamoxifen citrate. Iranian Polymer J 19: 437-446.
20. Moses MA, Brem H, Langer R (2003) Advancing the field of drug delivery: Taking aim at cancer. Cancer Cell 4: 337-341. (Pubitemid 37491094)
21. Mu L, Feng S (2003) A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86: 33-48. (Pubitemid 35469120)
22. Myers RH, Montgomery DC (1995) Response Surface Methodology: Process and Product Optimization Using Designed Experiments. London, John Wiley.
23. Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307: 93-102.
24. Pasandideh SHR, Niaki STA (2006) Multi-response optimization using genetic algorithm within desirability function framework. Appl Math Comput 175: 366-382.
25. Rafati H, Coombes AGA, Adler J, Holland J, Davis SS (1997) Protein-loaded poly (D,L-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J Control Release 43: 89-102. (Pubitemid 26393612)
26. Sahana DK, Mittal G, Bhardwaj V, Kumar MN (2008) PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticles formarion and release behavior in vitro and in vivo using stradiol as a model drug. J Pharm Sci 97: 1530-1542.
27. Sahoo S, Panyam J, Prabha S, Labhasetwar V (2002) Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82: 105-114. (Pubitemid 34775052)
28. Sáiz-Abajo MJ, González-Sáiz JM, Pizzarro C (2005) Multi-objective optimisation strategy based on desirability functions used for chromatographic separation and quantification of L-proline and organic acids in vinegar. Anal Chim Acta 528: 63-76. (Pubitemid 40092971)
29. Vandervoort J, Ludwig A (2002) Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm 238: 77-92. (Pubitemid 34457877)